Guys COK is in a downtrend. Don't tell the noobs it has promise, that's not good. It has made 3 consecutive lower peaks, a recent failed partial rise and has at least 2 major resistances to overcome before you should consider buying in.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
